Cargando…
B7-H3 Suppresses Antitumor Immunity via the CCL2–CCR2–M2 Macrophage Axis and Contributes to Ovarian Cancer Progression
New approaches beyond PD-1/PD-L1 inhibition are required to target the immunologically diverse tumor microenvironment (TME) in high-grade serous ovarian cancer (HGSOC). In this study, we explored the immunosuppressive effect of B7-H3 (CD276) via the CCL2–CCR2–M2 macrophage axis and its potential as...
Autores principales: | Miyamoto, Taito, Murakami, Ryusuke, Hamanishi, Junzo, Tanigaki, Kenji, Hosoe, Yuko, Mise, Nathan, Takamatsu, Shiro, Mise, Yuka, Ukita, Masayo, Taki, Mana, Yamanoi, Koji, Horikawa, Naoki, Abiko, Kaoru, Yamaguchi, Ken, Baba, Tsukasa, Matsumura, Noriomi, Mandai, Masaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414298/ https://www.ncbi.nlm.nih.gov/pubmed/34799346 http://dx.doi.org/10.1158/2326-6066.CIR-21-0407 |
Ejemplares similares
-
Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment
por: Horikawa, Naoki, et al.
Publicado: (2020) -
Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation
por: Taki, Mana, et al.
Publicado: (2018) -
Acquisition of a side population fraction augments malignant phenotype in ovarian cancer
por: Yamanoi, Koji, et al.
Publicado: (2019) -
Combination of gene set signatures correlates with response to nivolumab in platinum-resistant ovarian cancer
por: Murakami, Ryusuke, et al.
Publicado: (2021) -
VISTA expressed in tumour cells regulates T cell function
por: Mulati, Kumuluzi, et al.
Publicado: (2018)